Explorer les evidences

2 646 person-yearsParticipants in the Temprano ANRS 12136 posttrial phase were followed for 2646 person-years.

Côte d'IvoireVIH/sidapublié 2021Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument de 6 observations

0,56 probabilityThe 36-month probability of immunovirologic success was 0.56 in patients with a medication possession ratio (MPR) below 90%.

Côte d'IvoireVIH/sidapublié 2009AIDS research and human retroviruseseurope_pmcdocument de 2 observations

16,5 %The prevalence of left ventricular diastolic dysfunction was 16.5%.

Côte d'Ivoireleft ventricular diastolic dysfunctionobservé 2015publié 2021Southern African journal of infectious diseaseseurope_pmcdocument de 9 observationsDOI 10.4102/sajid.v36i1.187

46 patients46 patients had not been treated (74.2%).

Côte d'IvoireVIH/sidaobservé 1999–2006publié 2010Le Mali medicaleurope_pmcdocument de 17 observations

2 patientsAlcohol consumption was present in two patients.

Côte d'Ivoirealcohol consumptionpublié 2009Antiviral therapyeurope_pmcdocument de 11 observations

10 %Atypical haplotypes were detected in 10% of samples.

Côte d'Ivoirehemoglobinobservé 2022HAL · Unilimdocument de 23 observations

4,9 %Staphylococcus aureus was detected in 4.9% of afebrile people in Côte d'Ivoire.

Côte d'IvoireStaphylococcus aureuspublié 2021Travel medicine and infectious diseasePubMeddocument de 25 observations

36 yearsThe mean age of 491 adult HIV patients was 36 ± 8.68 years.

Côte d'IvoireVIH/sidaobservé 2006publié 2012World journal of hepatologyeurope_pmcdocument de 13 observations

10,49 %Malaria case prevalence in the LLIN plus Bti group was 10.49% (463/4415) post-intervention.

Côte d'IvoirepaludismeHAL · Unilimdocument de 54 observations

0,61 per_100_person_monthsDuring the post-intervention period, the crude incidence rates were 0.61 cases per 100 person-months in the LLIN plus BTI group.

Côte d'IvoirepaludismeHAL · Unilimdocument de 54 observations

22 %Among ART-naive HIV-1-infected adults in Côte d'Ivoire, 22% had signs of cured HBV infection.

Côte d'Ivoirehépatite B · VIH/sidapublié 2010Antiviral therapyeurope_pmcdocument de 7 observations

87 %In the per-protocol analysis, HIV RNA less than 50 copies/ml at 24 weeks was observed in 64 of 77 (87%) patients in the FZD arms.

Côte d'IvoireVIH/sidapublié 2017AIDS (London, England)europe_pmcdocument de 7 observations

23,2 %Among individuals without LLIN possession, malaria prevalence was 23.2%.

Côte d'IvoirepaludismeHAL · Unilimdocument de 122 observations

102 cells/mm³The median CD4 count was 102 cells/mm³.

Côte d'IvoireVIH/sidapublié 2024Open forum infectious diseaseseurope_pmcdocument de 9 observations

130 per_1000_person_yearsThe mean weekly malaria incidence throughout the year in the overall population corresponded to 130 cases per 1000 person-years.

Côte d'Ivoirepaludismeobservé 2016–2017HAL · Unilimdocument de 122 observations

166 cells/mm³The median CD4 count at ART initiation was 166 cells/mm³ among HIV-2 infected patients.

Côte d'IvoireVIH/sidapublié 2013PloS oneeurope_pmcdocument de 14 observations

25 %En Côte d’Ivoire en 2004, les chiffres de prévalence des otomycoses étaient identiques à ceux observés au Gabon en 1989 : 25 % des otites, dont 54 % dues à l’aspergillose et 17 % à A. flavus.

Côte d'Ivoireotomycosesobservé 2004HAL · Unilimdocument de 420 observations

2,2 log10_copies_per_mlMedian HBV DNA level was 2.2 log(10) copies/ml for patients with occult HBV infection.

Côte d'Ivoirehépatite Bpublié 2010Antiviral therapyeurope_pmcdocument de 7 observations

38,7 %After 24 months of follow-up, 12 out of 31 patients (38.7%) were still alive.

Côte d'Ivoireméningite cryptococciquepublié 2025IJID regionseurope_pmcdocument de 11 observations

31 %For adults living with HIV, bacterial infections were the second leading cause of hospital admission, accounting for 31% of admissions.

Côte d'Ivoirebacterial infectionspublié 2015The lancet. HIVeurope_pmcdocument de 8 observations

33,8 %The prevalence of malaria cases detected by RDTs among children aged 0–4 years was 33.8%.

Côte d'IvoirepaludismeHAL · Unilimdocument de 122 observations

44,6 %Among 65 HBsAg-positive participants, 29 (44.6%) had HBV-DNA levels > 10,000 copies/mL.

Côte d'Ivoirehépatite Bpublié 2017The American journal of tropical medicine and hygieneeurope_pmcdocument de 7 observationsDOI 10.4269/ajtmh.16-1016

8,1 %The frequency of thymidine analog mutations increased from 8.1% at month 12 to 14.7% at month 24 after ART initiation.

Côte d'IvoireVIH/sidapublié 2013Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument de 11 observations

26,6 %The prevalence of STI based on clinical symptoms was 26.6% among female sex workers enrolled in the PRINCESSE cohort in Côte d'Ivoire.

Côte d'Ivoiresexually transmitted infection (STI)publié 2025Frontiers in public healtheurope_pmcdocument de 7 observationsDOI 10.3389/fpubh.2025.1535122

24,2 %Among 273 included patients, 66 (24.2%) experienced non-clinical indicators relevant to HIV infection risk.

Côte d'IvoireVIH/sidaobservé 2013–2014publié 2017PloS oneeurope_pmcdocument de 5 observations